4.90
price down icon0.41%   -0.02
after-market Handel nachbörslich: 4.90
loading

Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.89%
8.153
7.557 5.952 2.856 7.808
Operating Expenses
6.98%
26.65
28.65 28.86 26.86 31.66
Benefits Costs and Expenses
-
- - 22.36 26.93
Costs And Expenses
6.98%
26.65
28.65 28.86 22.36 26.93
Operating Income/Loss
12.31%
-18.50
-21.10 -22.91 -24.00 -23.85
Nonoperating Income/Loss
16.10%
2.652
3.161 4.079 4.502 4.73
Income/Loss From Continuing Operations Before Tax
145.46%
8.153
-17.94 -18.83 -19.50 -19.12
Income/Loss From Continuing Operations After Tax
11.64%
-15.85
-17.94 -18.83 -19.50 -19.12
Net Income/Loss
11.64%
-15.85
-17.94 -18.83 -19.50 -19.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.08%
63.03
62.98 62.85 2.6575 62.60
Diluted Average Shares
0.08%
63.03
62.98 62.85 2.6575 62.60
Basic Earnings Per Share
10.71%
-0.25
-0.28 -0.30 -0.30 -0.31
Diluted Earnings Per Share
10.71%
-0.25
-0.28 -0.30 -0.30 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):